National Health Investors (NHI) Tops Q2 EPS by 6c

National Health Investors (NYSE: NHI) reported Q2 EPS of $0.93, $0.06 better than the analyst estimate of $0.87.

• Announced $25.4 million in real estate acquisitions and loans; $158.7 million year-to-date
• Maintained low leverage balance sheet at 4.3x net debt-to-annualized adjusted EBITDA
• Portfolio lease coverage remains strong at 1.76x
• GAAP net income of $.93 for the second quarter; $2.03 year-to-date
• Normalized FFO up 8.2% over second quarter 2016; up 8.0% year-to-date
• Normalized AFFO up 7.3% over second quarter 2016; up 7.9% year-to-date
• Amended $800 million unsecured bank credit facility, lowering interest rates to 115 bps and 130 bps over 30-day LIBOR on the revolving credit facility and term loans, respectively, based on current leverage

2017 Guidance

The Company currently expects Normalized FFO for 2017 to be in the range of $5.22 to $5.26 per diluted common share and Normalized AFFO to be in the range of $4.70 to $4.72 per diluted common share

For earnings history and earnings-related data on National Health Investors (NHI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook